Plasma Level Monitoring of Olanzapine in Patients With Schizophrenia

Therapeutic Drug Monitoring - Tập 19 Số 3 - Trang 307-313 - 1997
Manickam Aravagiri1,2, Donna Ames1, William C. Wirshing1, Stephen R. Marder1
1Psychopharmacology Unit, University of California at Los Angeles, Los Angeles, California, U.S.A.
2reprint requests to Manickam Aravagiri, West Los Angeles VAMC, Bldg. 210, Room 4, 11301-Wilshire Blvd., Los Angeles, CA 90073.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Snyder, 1976, Am J Psychiatry, 133, 197, 10.1176/ajp.133.2.197

Seeman, 1992, Neuropsychopharmacology, 7, 261

Creese, 1976, Science, 192, 481, 10.1126/science.3854

Casey, 1989, Psychopharmacology, 99, S47, 10.1007/BF00442559

Borison, 1995, J Clin Psychopharmacology, 15, 24S, 10.1097/00004714-199508001-00005

Peacock, 1996, Psychopharmacology, 124, 188, 10.1007/BF02245620

Van Putten, 1991, Schizophr Bull, 17, 197, 10.1093/schbul/17.2.197

Moore, 1992, J Pharmacol Exp Ther, 262, 545

Bymaster, 1996, Psychopharmacology, 124, 87, 10.1007/BF02245608

Beasley Jr, 1996, Psychopharmacology, 124, 159, 10.1007/BF02245617

Callow, 1995, J Chromatogr B, 668, 85, 10.1016/0378-4347(95)00061-M

Thông tin
Thông tin xuất bản

Therapeutic Drug Monitoring

Tập 19 Số 3

307-313

Thông tin tác giả